HCAT
Get informed when a big investor buys or sells
+ FollowUndervalued by 70.3% based on the discounted cash flow analysis.
| Market cap | $127.18 Million |
|---|---|
| Enterprise Value | $127.25 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.55 |
| Beta | 1.54 |
| Outstanding Shares | 73,960,000 |
| P/E Ratio | -0.46 |
|---|---|
| PEG | 42.67 |
| Price to Sales | 0.56 |
| Price to Book Ratio | 1.69 |
| Enterprise Value to Revenue | 0.44 |
| Enterprise Value to EBIT | -0.8 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.48 |
| Debt to Equity | 0.6 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 34.14% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.00%▼ 71.48% |
|---|---|
| Total Invested | $125▼ 100.00% |
| Investors Holding | 1▼ 136.00% |
No data